Summary

Diagnostic testing has been an indispensable tool in the fight against the COVID-19 pandemic.  Since the infectious period is limited to the first five to ten days of the infection, prompt results are needed to change behaviors to limit transmission.  Laboratory testing has allowed high sensitivity for patients coming in but can sometimes have extended turn-around times.  For many patients with milder symptoms, they may show up at physician offices and urgent care so point-of-care molecular tests may better satisfy that population.  Meanwhile, routine serial antigen tests have allowed schools and businesses to get back to face-to-face meetings and travel to resume. 

Learning Objectives

• Highlight situational rapid testing needs as the world transitions into the next stage of the pandemic.
• Differentiate rapid diagnostic tools and the value for acute and non-acute respiratory infections.
• Discuss best practices for integrating rapid testing into workflows.

Presenter Biography

Sheldon Campbell MD, PhD, FCAP
Professor of Laboratory Medicine
Yale School of Medicine
Associate Chief of Pathology and Laboratory
VA Connecticut Healthcare System

Deborah L. Birx, MD
Senior Fellow
George W. Bush Institute

Moderator

John Hackett
DVP Applied Research and Technology
Abbott

Who Should Watch

Healthcare professionals